Transcat, Inc. (NASDAQ:TRNS) Director Paul D. Moore sold 4,000 shares of the stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $13.00, for a total transaction of $52,000.00. Following the completion of the transaction, the director now directly owns 57,698 shares of the company’s stock, valued at approximately $750,074. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Transcat, Inc. (TRNS) traded up 1.1878% on Tuesday, reaching $13.3062. 10,179 shares of the company traded hands. The stock has a 50-day moving average price of $12.49 and a 200-day moving average price of $12.06. The firm has a market cap of $94.75 million, a P/E ratio of 21.1210 and a beta of 0.34. Transcat, Inc. has a 52-week low of $9.97 and a 52-week high of $14.05.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Tuesday, July 25th. The scientific and technical instruments company reported $0.12 earnings per share (EPS) for the quarter. The firm had revenue of $36.28 million during the quarter. Transcat had a net margin of 3.03% and a return on equity of 10.54%. Analysts anticipate that Transcat, Inc. will post $0.64 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/08/transcat-inc-nasdaqtrns-director-paul-d-moore-sells-4000-shares.html.

Hedge funds have recently bought and sold shares of the stock. QCI Asset Management Inc. NY increased its stake in Transcat by 10.0% in the second quarter. QCI Asset Management Inc. NY now owns 24,587 shares of the scientific and technical instruments company’s stock worth $299,000 after buying an additional 2,226 shares in the last quarter. Neuberger Berman Group LLC increased its stake in Transcat by 3.1% in the second quarter. Neuberger Berman Group LLC now owns 164,993 shares of the scientific and technical instruments company’s stock worth $2,005,000 after buying an additional 4,900 shares in the last quarter. Finally, WCM Investment Management CA increased its stake in Transcat by 0.7% in the second quarter. WCM Investment Management CA now owns 480,332 shares of the scientific and technical instruments company’s stock worth $5,836,000 after buying an additional 3,545 shares in the last quarter. 57.73% of the stock is owned by hedge funds and other institutional investors.

Transcat Company Profile

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Insider Buying and Selling by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc. and related companies with MarketBeat.com's FREE daily email newsletter.